Most viewed in the last 7 days from JAMA Oncology: Is having a spouse with cancer associated with risk of suicide attempt and suicide death? https://ja.ma/3AujaJe
JAMA Oncology
Book and Periodical Publishing
Chicago, Illinois 35,855 followers
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
Über uns
JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives more than 6.4 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 50 days with review. The Journal Impact Factor is 28.4, one of the highest ranking among oncology journals. All articles are published online first. Mary L. (Nora) Disis, MD, Director of the UW Institute of Translational Health Science and the Center for Translational Medicine in Women's Health, is the editor in chief.
- Website
-
https://jamanetwork.com/journals/jamaoncology
External link for JAMA Oncology
- Industrie
- Book and Periodical Publishing
- Größe des Unternehmens
- 5,001-10,000 employees
- Hauptsitz
- Chicago, Illinois
- Gegründet
- 2015
- Spezialitäten
- Oncology
Aktualisierungen
-
Authors Heather McGee, Terence Williams, and Percy Lee explain differences between recent studies using radiotherapy with immunotherapy and possible reasons for their different outcomes. https://ja.ma/3yHJnU7
-
-
While many clinical trials for metastatic breast, lung, colon, pancreatic, & prostate cancer are available in the US, they are not evenly distributed across the country and may not be accessible to all individuals. https://ja.ma/46PhBlc
-
-
Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe with initial intracranial control results that appear encouraging. https://ja.ma/4fTb7pu
-
-
A 62-year-old female had a generalized vesiculobullous rash on her face for 4 months. It started over the lips and gradually progressed to involve the oral mucosa and skin of the whole body. What is your diagnosis? https://ja.ma/46R4vE5
-
-
Most viewed in the last 7 days from JAMA Oncology: Is having a spouse with cancer associated with risk of suicide attempt and suicide death? https://ja.ma/4dBtn5m
-
-
In this systematic review and meta-analysis, incidence rates of Immune checkpoint inhibitor-induced CV adverse effects and myocarditis were low in clinical trials. While rare, myocarditis induced by ICI may be associated with substantial mortality. https://ja.ma/3WTGR5n
-
-
In this nonrandomized controlled trial, olaparib monotherapy led to high and durable PSA50 response rates in patients with high-risk biochemically recurrent prostate cancer following prostatectomy. https://ja.ma/3yPKwJl
-
-
Transarterial chemoembolization plus sorafenib for recurrent intermediate-stage hepatocellular carcinoma patients with microvascular invasion improved survival compared with transarterial chemoembolization alone. https://ja.ma/3M8vEJb
-
-
Additional survival time achieved by older adults with newly diagnosed AML receiving anthracyclines may have been entirely offset by admission to the hospital or to nursing facilities. https://ja.ma/3ArrB8h
-